| Title : Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects - He_2008_J.Clin.Pharmacol_48_85 |
| Author(s) : He YL , Ligueros-Saylan M , Sunkara G , Sabo R , Zhao C , Wang Y , Campestrini J , Pommier F , Dole K , Marion A , Dole WP , Howard D |
| Ref : Journal of Clinical Pharmacology , 48 :85 , 2008 |
| Abstract : He_2008_J.Clin.Pharmacol_48_85 |
| ESTHER : He_2008_J.Clin.Pharmacol_48_85 |
| PubMedSearch : He_2008_J.Clin.Pharmacol_48_85 |
| PubMedID: 17986525 |
He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D (2008)
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects
Journal of Clinical Pharmacology
48 :85
He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D (2008)
Journal of Clinical Pharmacology
48 :85